32 studies found for:
" May 20, 2009":" June 19, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Display Options
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
|
||||
| 2 | Completed |
Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients
|
||||
| 3 | Completed |
An Expanded Safety Study of Dapivirine Gel 4789 in Africa
|
||||
| 4 | Completed |
An Expanded Safety Study of Dapivirine Gel 4759 in Africa
|
||||
| 5 | Active, not recruiting |
Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya
|
||||
| 6 | Recruiting |
Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV
|
||||
| 7 | Completed |
Anal Cancer Screening Study
|
||||
| 8 | Active, not recruiting |
Natural History Study of HIV Acquired in Infancy or Childhood
|
||||
| 9 | Completed |
Evaluation of Cardiovascular Effects of Smoking Cessation in HIV Patients
|
||||
| 10 | Recruiting |
Safety and Immune Response Assessment Study of Killed-whole HIV-1 Vaccine (SAV001-H) in Chronic HIV-1 Infected Patients
|
||||
| 11 | Active, not recruiting |
CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
|
||||
| 12 | Completed |
Early Immune Responses to Vaccination - A Substudy to HVTN 205
|
||||
| 13 | Active, not recruiting |
New Era Study: Treatment With Multi Drug Class (MDC) HAART in HIV Infected Patients
|
||||
| 14 | Recruiting |
Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets
|
||||
| 15 | Completed |
A Study of Anti-HIV Monoclonal Antibody KD-247
|
||||
| 16 | Unknown † |
Exercise for Patients With HIV Infections
|
||||
| 17 | Completed |
Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
|
||||
| 18 | Unknown † |
TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age
|
||||
| 19 | Active, not recruiting |
Efficacy and Safety of Varenicline Among HIV-infected Patients
|
||||
| 20 |
Completed
Has Results |
A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents
|
† Indicates status has not been verified in more than two years
